Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Customized Neoadjuvant Therapy in Stage IIIA NSCLC
NCT01784549Phase 2Unknown
- Start
- Jul 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib, pemetrexed, vinorelbine, gemcitabine in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01784549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784549.